Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pneumatic Sleeves and Congestive Heart Failure (Sleeves-Bickel)

This study has been completed.
Information provided by (Responsible Party):
Western Galilee Hospital-Nahariya Identifier:
First received: September 9, 2012
Last updated: September 19, 2012
Last verified: September 2012
Based on the reversal of the adverse cardiovascular parameters during Laproscopic Surgery and its influence on cardiac activity in healthy subjects, the investigators expect to improved cardiac function in patients suffering from congestive heart failure.

Condition Intervention
Congestive Heart Failure
Device: Intermittent Sequntial Pnumatic Compression Leg Sleeves

Study Type: Interventional
Official Title: The Impact of Intermittent Sequential Pneumatic Compression (ISPC) Leg Sleeves on Cardiac Performance in Patients With Congestive Heart Failure

Resource links provided by NLM:

Further study details as provided by Western Galilee Hospital-Nahariya:

Primary Outcome Measures:
  • Cardiac Output

Secondary Outcome Measures:
  • Systemic vascular resistance

Other Outcome Measures:
  • Stroke volume

Arms Assigned Interventions
Experimental: Pneumatic Sleeves Device: Intermittent Sequntial Pnumatic Compression Leg Sleeves
Experimental: Congestive Heart Failure Patients Device: Intermittent Sequntial Pnumatic Compression Leg Sleeves


Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • CHF (as clinically evaluated and asessed by TTE)
  • Gave informed consent
  • NYHA Class II-III
  • LVEF equal or less than 40%

Exclusion Criteria:

  • Patients who could not sign informed consent
  • NYHA Class IV
  • Oxygen saturation less than 90% under room air
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01691417

Western Galilee Hospital
Nahariya, Israel, 22100
Sponsors and Collaborators
Western Galilee Hospital-Nahariya
  More Information

Responsible Party: Western Galilee Hospital-Nahariya Identifier: NCT01691417     History of Changes
Other Study ID Numbers: Sleeves-Bickel 
Study First Received: September 9, 2012
Last Updated: September 19, 2012
Health Authority: Israel: Ministry of Health

Additional relevant MeSH terms:
Heart Failure
Heart Diseases
Cardiovascular Diseases processed this record on October 25, 2016